CPT: 82985
Print Share

Expected Turnaround Time

Within 1 day

Related Documents

Specimen Requirements


Serum (preferred) or plasma


1 mL

Minimum Volume

0.2 mL (Note: This volume does not allow for repeat testing.)


Gel-barrier tube, transport tube, green-top (heparin) tube, or lavender-top (EDTA) tube


Separate serum or plasma from cells within 45 minutes of collection.

Storage Instructions

Maintain specimen at room temperature.

Stability Requirements



Room temperature

7 days


14 days


14 days

Freeze/thaw cycles

Stable x2

Causes for Rejection

Gross hemolysis; improper labeling; gross lipemia

Test Details


Evaluate diabetic control, reflecting diabetic control over a shorter time period (one to three weeks) than that represented by hemoglobin A1c (four to eight weeks). Indicated as an index of longer-term control than glucose levels, especially in diabetic subjects with abnormal hemoglobins and in type 1 diabetes in children.1



Additional Information

Fructosamine is found in the plasma of both normal and diabetic individuals. “Fructosamine” is the term used to describe proteins that have been glycated (ie, are derivatives of the nonenzymatic reaction product of glucose and albumin). It has been advocated as an alternative test to hemoglobin A1c for the monitoring of long-term diabetic control. Fructosamine and hemoglobin A1c do not measure exactly the same thing, since fructosamine has a shorter half-life and appears to be more sensitive to short-term variations in glucose levels; however, this is not necessarily a disadvantage. Fructosamine is clearly superior in patients with abnormal hemoglobins because of the interference of abnormal hemoglobins in the anion-exchange chromatography methods for Hb A1c. Published reference interval for apparently healthy subjects between age 20 and 60 is 205−285 μmol/L and in a poorly-controlled diabetic population is 228−563 μmol/L with a mean of 396 μmol/L.


1. Cefalu WT, Mejia E, Puente GR, Fleishhacker D, Macaulay K. Correlation of serum fructosamine activity in type I diabetic children. Am J Med Sci. 1989 Apr; 297(4):244-246. 2705464


Croxson SC, Absalom S, Burden AC. Fructosamine in diabetes screening of the elderly. Ann Clin Biochem. 1991 May; 28(Pt 3):279-282. 1872575
Melzi d'Eril GV, Bosoni T, Solerte SB, Fioravanti M, Ferrari E. Performance and clinical significance of the new fructosamine assay in diabetic patients. Wien Klin Wochenschr Suppl. 1990; 180:60-63. 2321395
Narayanan S. Laboratory monitoring of gestational diabetes. Ann Clin Lab Sci. 1991 Nov-Dec; 21(6):392-401. 1781664


Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
100800 Fructosamine 15069-8 100808 Fructosamine umol/L 15069-8

For Providers

Please login to order a test

Order a Test

© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at Additional information regarding LOINC® codes can be found at, including the LOINC Manual, which can be downloaded at